metformin vs glp 1 Disproportionality analysis of GLP-1 receptor agonists combined with based on the FAERS database Baseline characteristics of GLP-1 and

Chasing the wrong concern

Insulin secretagogues: Sulfonylureas, meglitinides, D-phenylalanine derivatives Those reducing insulin resistance: Biguanides Thiazolidinediones (glitazones) Those decreasing carbohydrate absorption from the gut: Alpha Glucosidase inhibitors

A marked induction of GST isoenzymes could contribute to a strong and possibly early symptomless type of resistance, while a less increase or a decrease of GST activity may confer only a weak virus resistance that eventually results in susceptibility (Gullner et al., 1995b)

IGF-1 DES has a shorter half-life and more localized effect, which means it carries less systemic risk but more site-specific irritation

Bariatric surgery for Prader-Willi syndrome was ineffective in producing sustainable weight loss: Long term results for up to 10 years